Gwagwarmaya da SARS-COV-2 tare

Yin gwagwarmaya da SARS-COV-2 tare (2)

Gwagwarmaya da SARS-COV-2 tare

A farkon 2020, wani mutumin da ba a gayyace shi ba ya fasa wadatar Sabuwar Shekara don ɗaukar kanun labarai a duniya - SARS-COV-2.

Sars-cov-2 da sauran coronaviruses suna raba irin wannan hanyar watsawa, galibi ta hanyar ɗigon numfashi da lamba.Alamomin kamuwa da cuta na yau da kullun a cikin mutane sune zazzabi, tari, da wahalar numfashi

Yin gwagwarmaya da SARS-COV-2 tare (3)

Idan zazzabi kawai, tari, ko dole ne a kamu da SARS-COV-2

A'a, saboda yawancin cututtuka da kwayar cutar ta mamaye jikin mutum, tsarin garkuwar jiki zai amsa, kuma zazzabi, atishawa, tari shine tsarin garkuwar jiki a cikin aikin waje, akwai alamun bayyanar cututtuka na SARS. - COV - 2, zaka iya amfani dakayan gwajin gaggawa na SARS-COV-2wannan ganewar asali ko kamuwa da SARS - COV - 2, sannan a warke da sauri.

Yin gwagwarmaya da SARS-COV-2 tare (4)

Dangane da sabon ƙwarewar asibiti a China, bayan kamuwa da ɗan adam tare da sabon coronavirus, ana iya fara gano shi a cikin lavage na huhu.Tare da ci gaba da cutar, ƙananan ƙwayar numfashi, na sama na numfashi, nasopharynx da sauran sassa za su ci gaba da bayyana, sa'an nan kuma an gano kwayar cutar a cikin jini.Saboda rashin tabbas na wuraren gwajin ƙwayoyin cuta da kasancewar manyan dillalai, mahimmancin asibiti na sabon gwajin rigakafin kambi ya zama mahimmanci musamman!Gwajin gwaji na asibiti a asibitoci uku a kasar Sin ya nuna cewa, tare da yanayin kiwon lafiya na yanzu, daidaiton gwaje-gwajen rigakafin rigakafi ya fi kashi 30 sama da na gwajin antigen.

Yin gwagwarmaya da SARS-COV-2 tare (5)

TheKayan gwajin gaggawa na SARS-COV-2zai yi wasa da sauri / inganci / sauƙi don aiki da sauran halaye, dacewa da yanki na farko na annoba don yin saurin dubawa, don guje wa jiran dogon sakamakon gano PCR, amma kuma don guje wa wahalar gurɓataccen iska wanda ke da sauƙin bayyana a ciki. PCR daga baya.

Yin gwagwarmaya da SARS-COV-2 tare (1)

A karkashin jagorancin farfesa Zhu Chenggang na jami'ar Zhejiang, an kammala aikin tare da hadin gwiwar cibiyar nazarin halittu ta kwalejin kimiyya ta kasar Sin da hadin gwiwar fasahar Hangzhou Antigen, LTD.Ƙungiyarmu ta ƙunshi ƙungiyar manyan ƙwararrun ƙwararrun masana a cikin filin bincike mai sauri, don mayar da martani ga abubuwan da ba za a yi tsammani ba sun tara isassun fasaha na fasaha, a cikin 2008 "melamine", taron "clenbuterol" a cikin 2011 yana da adadi na tawagarmu, kuma a cikin wannan biyu. Shekaru da yawa cutar zazzabin aladu na Afirka ta barke cikin sauri, don rigakafin cutar zazzabin aladu na Afirka ya ba da gudummawar da ta dace.

Mun yi imanin cewa za mu iya ba da gudummawa ga lafiyar duniya.


Lokacin aikawa: Fabrairu-27-2020

Aiko mana da sakon ku:

Ku rubuta sakonku anan ku aiko mana